Future plans aim at documenting our product in all major sub-populations and conditions, where injectable iron is necessary or clinical convenient in order to restore adequate iron-levels.
Future plans include establising a network of strong speciality-pharma companies that are capable of exploring the huge potential of our Polyglucoferron product.
We will assess the most cost-effective strategies for the world-wide marketing and be open for:
- Partnerships with pharmaceutical companies
- Licensing agreements
- Establishment of own subsidiaries